Protein Assays Market - Emerging Revenue Growth Boosters & Future Forecasts

 Protein assays are used in life science research to determine the total protein concentration. Estimation of protein concentration is necessary for protein purification, electrophoresis, cell biology, molecular biology, and research applications. The market is witnessing high growth due to factors such as increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for Proteomics research.

Revenue Growth Expectations:

The Protein Assays Research Procedure Market is expected to be valued at USD 1.42 Billion in 2017 and is projected to grow at a CAGR of 11.1% between 2017 and 2022, to reach USD 2.41 Billion in 2022.

Growth Boosting Factors:

The increasing pharmaceutical & biotech R&D expenditure and the favorable government funding scenario for proteomics research are the major factors that are expected to drive the growth of the market during the forecast period.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93720547

Target Audience for this Report:

# Protein assay manufacturers and vendors
# Distributors of protein assays
# Various research and consulting companies
# Associations related to pharmaceutical and biotechnological research

Value Addition for the Buyer:

This report aims to provide insights into the global protein assays market. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

The protein assays market, by product, is segmented into reagents, kits, and instruments & accessories. In 2017, the reagents segment is expected to account for the largest share of this market.

The Protein Assays Research Procedure Market, by application, is segmented into disease diagnosis, drug discovery & development, and other applications. The disease diagnosis segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing adoption of protein assays used to diagnose cancer; immune system diseases; and liver, kidney, and bone marrow diseases.

End Users:

On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, clinical laboratories, hospitals, academic research institutes, and other end users. In 2017, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. The growth in this segment can primarily be attributed to the increasing drug development in the life science industry.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=93720547

Geographical Growth Scenario:

Based on region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China, India, and Japan; the increasing R&D expenditure in life science, and increasing private-public partnerships for proteomics research are some major factors driving the growth of this regional segment.

Key Players:

Key players operating in the Protein Assays Research Procedure Market include Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Environmental Testing Equipment Market - Global Future Forecasts by 2023

 Overview of This Study:

The study involved four major activities to estimate the current market size for environmental testing equipment. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Revenue Growth Expectations:

The environmental testing equipments market is expected to grow from USD 2.1 billion in 2018 to USD 2.9 billion by 2023, at a CAGR of 7.1% during the forecast period. Growth in the market is primarily driven by factors such as rising levels of environmental pollution worldwide, increasing government regulations and initiatives for environmental protection, privatization of environmental testing services, and increasing focus on wastewater treatment.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=149706080

Air testing applications are expected to grow at the highest CAGR in the global environmental testing equipment market during the forecast period

On the basis of application, the market is segmented into water testing, air testing, and soil testing. The water testing segment commanded the largest share of the market in 2018. However, the air testing market is projected to register the highest CAGR owing to the increasing fatalities caused by severe air pollution levels. Increasing fatalities caused by severe air pollution levels is a major factor driving growth in the application segment.

Key Questions Addressed by the Report:

# Which of the product segment will dominate the global market in the next five years?
# Emerging countries have immense opportunities for the growth and adoption of environmental testing equipment, will this scenario continue in the next five years?
# Increasing environmental awareness in the emerging market is impacting the growth for developed markets. How will the pricing difference impact the overall market?
# What are the upcoming technologies in the global market?

Geographical Growth Scenario:

North America is expected to dominate the environmental testing equipment market during the forecast period

Geographically, North America is expected to dominate the global environmental testing equipments market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the rising outdoor air pollution levels, the availability of government funding, and stringent environmental monitoring regulations.

Key Players:

The major players operating in the environmental testing equipments market include Agilent Technologies (US), Thermo Fisher Scientific (US), and Shimadzu Corporation (Japan). Other players involved in this market include Waters Corporation (US), Bruker (US), PerkinElmer (US), SCIEX (a subsidiary of Danaher) (US), JEOL (Japan), Analytik Jena (Germany), and Merck KGaA (Germany).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=149706080

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

ePrescribing Market - Services Industry to Provide Opportunities for Revenue Generation

 Overview of This Study:

The study involved four major activities in estimating the size of the global ePrescription Mechanism Market. Exhaustive secondary research was done to collect information on the utilization of different solutions and their regional utilization trends. Industry experts further validated the data obtained through secondary research through primary research.

Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level adoption of various EHR solutions and utilization of ePrescribing funcitonality) and top-down approach (assessment of utilization/adoption/penetration trends, by type of product& service, delivery mode, end user, and region). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments.

Market Size Estimation:

The total market size for the ePrescribing market was arrived at after data triangulation from two different approaches, as mentioned below.

Approach 1: Parent Market Analysis

In this report, the global market size for the Revenues of individual companies providing EHR solutions with the integrated e-prescribing module was gathered from public sources and databases. Shares of the EHR market provided by leading players were gathered from secondary sources to the extent available.  Individual shares or revenue estimates were validated through expert interviews

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=910

Approach 2: Demand Side Analysis

In the case of demand-side analysis, the total number of physicians utilizing the e-prescribing module was studied using secondary and primary research. All the responses were collated to derive a probabilistic estimate of the market size based on the annual and implementation costs per physician per year.

Target Audience:

# Providers of e-prescribing systems and solutions
# E-prescribing service providers
# EHR and EMR vendors
# Hospitals and clinics
# Pharmacies
# Pharmacy benefit managers
# Pharmacy system vendors
# Healthcare insurance providers
# Regulators and associations
# Market research and consulting firms
# Venture capitalists and investors

Revenue Growth Projections:

The global ePrescribing market size is projected to reach USD 3.3 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 23.3%.

Growth Influencing Factors:

Factors such as the increasing adoption of EHR solutions, government initiatives and incentive programs, rising focus on reducing the abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail the escalating healthcare costs are driving the growth of the ePrescription Mechanism Market. Additionally, the onset of the COVID-19 pandemic has accelerated the use of telemedicine modules and telehealth consultations. This is further driving the adoption of e-prescribing solutions.

Data Triangulation:

After arriving at the overall ePresciribng market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Recent Developments in the Global ePrescribing Market:

# In April 2020, DrFirst (US) partnered with ID.me (US) to help users of the company’s e-prescribe app to verify their identities within a few minutes. This is expected to speed up the process for clinicians to prescribe drugs.

# In July 2019, NextGen Healthcare(US) announced its partnership with Optimize Rx (US) to provide real-time access to critical financial information, allowing providers to help patients choose appropriate medication plans, as per their cover and budgets. This tool has been integrated with the company’s ehr workflow.

# In june 2019, Allscripts (US) acquired ZappRx (US) to help Veradigm’s e-prescribing solutions by integrating it with the automate prior authorization platform, thus adding value to its existing platform.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=910

Geographical Growth Scenario:

North America will continue to dominate the ePrescribing market in 2025

In 2019, the large share of this North American region can be attributed to the stringent legislative and accreditation requirements regarding healthcare, high adoption of HCIT technologies, regulatory requirements regarding patient safety, and the presence of a large number of e-prescribing solution providers in the region.

Key Players:

Prominent players in the global ePrescription Mechanism Market are Epic Systems Corporation (US), Cerner Corporation (US), Allscripts (US), NextGen Healthcare (US), athenahealth, Inc. (US), RelayHealth, LLC (US), Henry Schein, Inc. (US), GE Healthcare (US), Computer Programs and Systems Inc. (US), DrFirst, Inc. (US), Surescripts-RxHub, LLC (US), and Medical Information Technology, Inc. (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Transfection Reagents and Equipment Market - Global Key Players & Different Growth Strategies Adopted by Them

 The key players in this market are continuously striving to gain larger shares and expand their existing product portfolios by agreements, collaborations, and partnerships. The overall market was dominated by Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands). Other players include Polyplus-transfection SA (France), Bio-Rad Laboratories Inc. (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte, Inc. (U.S.).

Thermo Fisher Scientific Inc. (U.S.) is leading player in the transfection reagents and equipment market with a market share of ~61.5% in 2015. The company primarily focuses on growth strategies such as acquisitions to add innovative technologies and products to its portfolio, which in turn helps the company to strengthen its presence in the respective markets. Thermo Fisher acquired Affymetrix, Inc. (U.S.) in 2016, Advanced Scientifics, Inc. (U.S.) in 2015, and Life Technologies Corporation (U.S.) in 2014. This helped the company to expand its customer base and significantly boost its market share. The company’s major share in the transfection reagents and equipment market can be attributed to its broad product portfolio, years of experience, and extensive distribution channel.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139141146

The R&D expenditure of the company for 2015 was USD 690 million, which enabled it to expand its product portfolio in the transfection reagents and equipment market, and to further enhance its customer base. In November 2014, Thermo Fisher Scientific introduced its Lipofectamine MessengerMAX, a high-efficiency transfection reagent for mRNA delivery in neurons and primary cell types. It is five times more efficient as compared to DNA reagents and helps researchers in easy transfection of biologically relevant cell models without electroporation or viruses. The company‘s distribution network comprises a broad sales force and global network of resellers and distributors. Thermo Fisher has approximately 17,500 sales and service personnel, including over 3,000 trained technical specialists who address the diversified demands of technical end users.

Promega Corporation (U.S.) is another dominant player in the transfection reagents and equipment market. The company accounted for approximately ~17.4% of the market revenue generation. The firm offers more than 3000 products for life science research, particularly in genomics, protein analysis and expression, cellular analysis, drug discovery, and genetic identity. It offers various transfection reagents under its reporter assays and transfection category of products. Promega has branches in 16 countries with more than 50 global distributors. The company possesses a strong intellectual property portfolio, which helps it to maintain its position in the life science market. Promega owns more than hundred patents in the field of nucleic acid purification, human identification, bioluminescence, coupled in vitro transcription and translation, and cell biology. The company focuses on the strategy of new product development and expansion to strengthen its position in the market.

Players operating in the transfection reagents and equipment market adopted strategies such as agreements, collaborations, and partnerships to strengthen their global presence. The key players that have adopted these strategies include MaxCyte, Inc. (U.S.), Polyplus-transfection SA (France), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), F. Hoffmann-La Roche ltd (Switzerland), and Thermo Fisher Scientific Inc. (U.S.).

Expected Revenue Growth:

The global transfection reagent market includes forecast from 2016 to 2021. This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.

Growth Boosting Factors:

This growth can be attributed to factors such as advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer. Moreover, development of large scale transfections, rising demand of protein therapeutics, and emerging markets across India and China are likely to create opportunities for players operating in the market.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=139141146

Geographical Growth Scenario:

On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Reporter Gene Assays Market worth $2.6 Billion by 2024

The reporter gene assays market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2019, at a CAGR of 10.1%. The major factors driving the growth of this market include increasing funding for cell-based research, growing applications of gene expression, and a rising preference for cell-based assays.

By product, the Assay kits segment to dominate the reporter gene assays market in 2019

On the basis of product, the market is broadly split into reagents and assay kits. The assay kits segment is expected to account for the larger share of the reporter gene assays market in 2019. The large share of the assay kits segment can be attributed to their repeated use in gene expression studies and signaling pathway analysis during gene transcription or translation levels. Assay kits are preferred over standalone reagents in cases where a validated protocol for assay development is available. Assay kits not only save time but also offer technological advantages, easy availability, and greater convenience.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20053198

By application, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period (2019-2024)”

Based on application, the reporter gene assays market is segmented into gene regulation, protein interaction, cell signaling pathways, and promotor structural & functional analysis. In 2019, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed to its importance in several cellular functionalities (such as cell differentiation, cell fate determination, and cell growth) and advanced applications of cell signaling in life science sectors (such as biotechnology, molecular biology, and microbiology).

North America to hold the largest regional market share in 2019

North America is expected to account for the largest share of the reporter gene assays market in 2019, followed by Europe. The large share of North America in the global market can be attributed to the growing academic and government investments in genomics and proteomics research; rising demand for cell-based assays in research; increasing focus on cell-based therapeutics; and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes.

Key Players:

The prominent players in the reporter gene assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Danaher Corporation (US), Geno Technology (US), Genecopoeia, Inc. (US), InvivoGen (France), PromoCell (Germany), Becton, Dickinson and Company (US), Biotium, Inc. (US), Canvax (Spain), LI-COR, Inc. (US), System Biosciences, LLC (US), Indigo Biosciences, Inc. (US), BioThema (Sweden), Takara Bio Inc (US), BioAssay Systems (US), Cell Biolabs, Inc. (US), BPS Bioscience, Inc (US), Biosynth AG (Switzerland), and Cayman Chemical (US).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=20053198

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Sample Preparation Market worth 7,203.2 Million USD by 2021

 The sample preparation market comprises products used to prepare biological as well as chemical samples for the analysis of raw materials or final products primarily to determine the presence of unwanted materials. Sample preparation instruments, workstations, and consumables serve the purpose of the production of a homogeneous sub-sample, representative of the material submitted to a laboratory.

The market is expected to grow at a CAGR of 5.5% during the forecast period to reach USD 7,203.2 Million by 2021 from an estimated USD 5,512.2 Million in 2016. The market growth can be attributed to increasing research activities in genomics, shift from manual sample preparation to workstations, global alliances among leading research institutes to boost drug discovery, rising adoption of modern extraction techniques, technological advancements in analytical instruments, increasing life sciences R&D spending, and increasing need for food analysis due to safety concerns.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66938505

The sample preparation market comprises products used to prepare biological as well as chemical samples for the analysis of raw materials or final products primarily to determine the presence of unwanted materials. Sample preparation instruments, workstations, and consumables serve the purpose of the production of a homogeneous sub-sample, representative of the material submitted to a laboratory.

The sample preparation market has been segmented, on the basis of product, into workstations/systems, consumables, and accessories. The consumables segment is estimated to witness the highest CAGR during 2016–2021. The high growth can be attributed to the recurring purchase of these products. The consumables segment of the global sample preparation market is broadly segmented into kits, columns, filters, tubes, plates, and other consumables.

By applications, the market is broadly segmented genomics, proteomics, epigenomics and epigenetics, and other applications. In 2016, the genomics segment accounted for the largest share of the sample preparation market. The largest share of this segment can be attributed to a number of automated solutions that are emerging for improving sample preparation process efficiency and quality in various genomic applications, such as DNA extraction, normalization, PCR setup, DNA shearing, and next-generation sequencing. Automation reduces errors and thus reduces the cost per PCR test, thereby driving the market.

By end user, the market is segmented into pharmaceutical and biotechnology industries, research and academic institutes, food and beverage industry, and other end users. In 2016, the pharmaceutical and biotechnology industries segment accounted for the largest share of the sample preparation market. With continuous research activities in pharmaceutical and biotechnology companies, there is a greater focus on the introduction of new technologies in the market. In this regard, sample preparation techniques aid in providing rapid analysis, and accurate results while handling different and multiple samples.

Geographically, the North American market accounted for the largest share of the global sample preparation market in 2016. The large share can be attributed to factors such as steady increase in laboratory spending, advances in forensic sciences, and initiation of the Genomic Applications Partnership Program (GAPP) as well as the growing food testing industry in Canada are some of the key factors driving the growth of the sample preparation market in North America.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=66938505

Key Players:

Prominent players in the global sample preparation market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Hamilton Company (U.S.), Norgen Biotek Corporation (Canada), Roche Applied Science (Switzerland), Tecan Group (Switzerland), Sartorius (Germany), Merck (Germany), and Promega Corporation (U.S.).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com